Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 6,630 KRW
Change Today +40.00 / 0.61%
Volume 505.1K
039200 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:29 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

oscotec inc (039200) Snapshot

Open
6,590
Previous Close
6,590
Day High
6,890
Day Low
6,500
52 Week High
08/13/15 - 8,270
52 Week Low
10/13/14 - 1,645
Market Cap
160.7B
Average Volume 10 Days
947.0K
EPS TTM
-91.00
Shares Outstanding
24.2M
EX-Date
12/29/11
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OSCOTEC INC (039200)

Related News

No related news articles were found.

oscotec inc (039200) Related Businessweek News

No Related Businessweek News Found

oscotec inc (039200) Details

Oscotec Inc. engages in drug discovery for osteoporosis, arthritis, periodontal, and cancer diseases in South Korea. Its product pipeline for osteoporosis disease includes OCT-1547, a Phase I clinical trial stage drug that inhibits osteoclast differentiation; and ODS-656, which increases bone formation by accelerating osteoblast differentiation. The company’s product pipeline for arthritis disease comprises SYK inhibitor that inhibits SYK; BT-201, a preclinical test stage drug for anti-inflammation and bone/cartilage protection; and ADAMTS-5 inhibitor for protecting cartilage by inhibiting cartilage destruction enzyme. Its product pipeline for periodontal disease drugs consists of BT-301, a Phase II clinical trial stage drug involved in the anti-inflammation and alveolar bone protection. The company’s product pipeline for cancer disease includes FLT-3 inhibitor, a preclinical test stage drug that inhibits FLT3, which is hyper-activated in acute myeloid leukemia; and HIF-143, a preclinical test stage drug for the inhibition of reactive oxygen species generation in cancer cells. It also offers dental health products, such as bone graft comprising InduCera, SynCera, and BioCera-F; membrane consisting of CollaGuide; and centrifuge, including PRP/PRF centrifuge and PRP reagents. The company was formerly known as Oscotec Co., Ltd and changed its name to Oscotec Inc. in June 1999. Oscotec Inc. was founded in 1998 and is based in Seongnam, South Korea.

Founded in 1998

oscotec inc (039200) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

oscotec inc (039200) Key Developments

Oscotec Inc., Annual General Meeting, Mar 27, 2015

Oscotec Inc., Annual General Meeting, Mar 27, 2015., at 09:00 Korea Standard Time. Location: Korea Bio Park, Great gyo 700 B1 Auditorium. Agenda: To consider the financial statements; to consider the appointment of directors; and to consider the remuneration of directors.

Oscotec Inc., Special/Extraordinary Shareholders Meeting, Dec 30, 2014

Oscotec Inc., Special/Extraordinary Shareholders Meeting, Dec 30, 2014., at 09:00 Korea Standard Time. Location: Korea Bio Park Great gyo 700 B1 Auditorium. Agenda: To thank Chang-Nam Kim re-election any cases.

Oscotec Inc., Annual General Meeting, Mar 21, 2014

Oscotec Inc., Annual General Meeting, Mar 21, 2014., at 09:00 Korea Standard Time. Location: Great Place Pangyo 700. Agenda: To consider approval of the 16th financial statement; to consider the approval of director remuneration; and to consider the audit approval of remuneration.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
039200:KS 6,630.00 KRW +40.00

039200 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 039200.
View Industry Companies
 

Industry Analysis

039200

Industry Average

Valuation 039200 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.7x
Price/Book 6.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OSCOTEC INC, please visit www.oscotec.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.